Definitive conformal radiotherapy for localized prostate cancer: a long-term follow-up study.

Background: The present study analyzed the clinical long-term outcome of patients with localized prostate cancer after definitive conformal radiotherapy with and without accompanying androgen deprivation (AD).

Patients And Methods: From 1996 to 2000, 210 patients (median age: 69 years; range: 54-82 years) with a localized prostate cancer (T1/T2: 72%; initial PSA <10: 39%; Gleason <7: 65%) were treated at Hannover Medical School. Fourteen percent of the patients were classified as low risk (LR), 40% as intermediate risk (IR) and 43% as high risk (HR) according to the ASTRO consensus definition.